Introduction: Due to concerns of oxidative stress and injury, most clinicians currently use lower levels of fractional inspired oxygen (FiO₂, 0.21–0.3) to initiate respiratory support for moderate to late preterm (MLPT, 32–36 weeks gestation) infants at birth. Whether this practice achieves recommended oxygen saturation (SpO₂) targets is unknown. Methods: We aimed to determine SpO₂ trajectories of MLPT infants requiring respiratory support at birth. We conducted a prospective, opportunistic, observational study with consent waiver. Preductal SpO₂ readings were obtained during the first 10 min of life from infants between 32 and 36 weeks gestation requiring respiratory support in the delivery room. Primary outcome was reaching a minimum SpO₂ 80% at 5 min of life. The study was prospectively registered (ACTRN12620001252909). Results: A total of 76 eligible infants were recruited between February 2021 and March 2022 from 5 hospitals in Australia. Most (n = 58, 76%) had respiratory support initiated with FiO₂ 0.21 (range 0.21–1.0) using CPAP (92%). Median SpO₂ at 5 min was 81% (interquartile range [IQR] 67–90) and 93% (IQR 86–96) at 10 min. At 5 min, 18/43 (42%) infants had SpO₂ below 80% and only 8/43 (19%) reached SpO₂ 80–85%. Conclusions: Many MLPT infants requiring respiratory support do not achieve recommended SpO₂ targets. In very preterm infants, SpO₂ <80% at 5 min of life increases risk of death, intraventricular haemorrhage, and neurodevelopmental impairment. The implications on this practice on the health outcomes of MLPT infants are unclear and require further research.
No takes yet. Share an insight, caveat, or question.
Sotiropoulos et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: